Insider Buying: Oscar Health, Inc. (NYSE:OSCR) Director Purchases 420,819 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was acquired at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the completion of the transaction, the director now directly owns 5,452,081 shares of the company’s stock, valued at approximately $74,584,468.08. This trade represents a 8.36 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Oscar Health Stock Performance

NYSE OSCR opened at $14.85 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $6.93 and a twelve month high of $23.79. The business has a 50-day moving average price of $18.20 and a 200-day moving average price of $18.26. The firm has a market cap of $3.59 billion, a price-to-earnings ratio of -247.50 and a beta of 1.67.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The business had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.29) earnings per share. As a group, equities research analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Institutional investors have recently bought and sold shares of the stock. Wealth Enhancement Advisory Services LLC lifted its stake in Oscar Health by 7.5% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock worth $255,000 after purchasing an additional 844 shares in the last quarter. American International Group Inc. increased its holdings in shares of Oscar Health by 1.3% in the first quarter. American International Group Inc. now owns 79,411 shares of the company’s stock worth $1,181,000 after purchasing an additional 1,009 shares during the last quarter. Summit Trail Advisors LLC lifted its position in shares of Oscar Health by 5.4% in the second quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock worth $329,000 after buying an additional 1,065 shares in the last quarter. KBC Group NV boosted its stake in Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after buying an additional 1,328 shares during the last quarter. Finally, Arizona State Retirement System grew its holdings in Oscar Health by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after buying an additional 1,351 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on OSCR. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Finally, Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.